Search clinical trials for: repaglinide; midazolam; SHR4640 placebo

Total 157 results

Jiangsu HengRui Medicine Co., Ltd.

Completed

PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval

Gout and Hyperuricemia

China
Atridia Pty Ltd.

Completed

A Single Dose Study of SHR4640 in Healthy Male Volunteers

Gout

Australia
Jiangsu HengRui Medicine Co., Ltd.

Completed

Multiple Dose Study of SHR4640 in Healthy Subjects

Gout; Hyperuricemia

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Single Dose Study of SHR4640 in Healthy Subjects

Gout; Hyperuricemia

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Primary Gout and Hyperuricemia
Arbelaez, Ana Maria
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo... and other collaborators

Completed

Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis

Pancreatic Insufficiency | Cystic Fibrosis Related Diabetes

United States
Steno Diabetes Center Copenhagen

Completed

Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet

Diabetes Mellitus, Type 2

Denmark
Novo Nordisk A/S

Completed

Efficacy of Repaglinide in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Italy
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC

Prostate Cancer | Castration-resistant Prostate Cancer

China
Steno Diabetes Center Copenhagen

Completed

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

Diabetes Mellitus, Type 2

Denmark
Jiangsu HengRui Medicine Co., Ltd.

Completed

Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia

Hyperuricemia

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Prostate Cancer Patients

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy

Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout

Gout

China
Boehringer Ingelheim

Recruiting

A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood

Healthy

Belgium
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers

Rheumatoid Arthritis

China
Takeda

Completed

A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults

Healthy Volunteers

United States
Atriva Therapeutics GmbH

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib

Healthy

Germany
Korea University Anam Hospital

Completed

A Study on the Effects of Midazolam on Delirium After Sevoflurane Anesthesia in Pediatric Strabismus Surgery

Child | Anesthesia Morbidity | Delirium on Emergence

Korea, Republic of
Shire

Terminated

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo

Adenoviral Conjunctivitis

United States, Puerto Rico
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

Preoperative Oral Midazolam to Postoperative Pain Relief in Sleep Disturbance or Anxiety Patients With Colorectal Cancer (POMPPR)

Pain, Postoperative | Anxiety | Sleep Disturbance | Preoperative | Midazolam

China
GlaxoSmithKline

Completed

A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

Infections, Bacterial

Australia
Shire

Terminated

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

Adenoviral Conjunctivitis

United States, Israel, France, India, Australia, Austria, Spain, Estonia, Hungary, Poland, South Africa, Canada, Germany, Italy, Peru, United Kingdom
Insel Gruppe AG, University Hospital Bern
University Hospital, Basel, Switzerland; University Hospital, Zürich; Stadtspital...

Not yet recruiting

Administration of Intranasal Midazolam for Anxiety in Palliative Care (AIM Care)

Anxiety | Acute Anxiety

Switzerland
Mayo Clinic

Completed

Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery

Anxiety | Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma

United States
Taipei Veterans General Hospital, Taiwan

Recruiting

Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression

Major Depressive Disorder | Treatment-resistant Depression

Taiwan
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Cancer

China
Washington University School of Medicine
Society of Pediatric Urology

Terminated

Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

Vesicoureteral Reflux

United States
Janssen Research & Development, LLC

Completed

Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide

Depressive Disorder, Major

United States, France, Italy, Spain, Hungary, Belgium, Brazil, Bulgaria, Poland
Shire

Completed

Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo

Bacterial Conjunctivitis

United States, Australia, Austria, Israel, Poland, Hungary, South Africa, Canada, Estonia, France, Italy, Spain, Puerto Rico
Crinetics Pharmaceuticals Inc.

Completed

Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers

Healthy Volunteers

Australia
University of Oklahoma

Terminated

Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety

Anxiety

United States
Erasme University Hospital

Completed

Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial

Anxiety | Cirrhosis | Chronic Hepatitis

Belgium
Jiangsu HengRui Medicine Co., Ltd.

Completed

The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

Prostate Cancer Patients

China
Pfizer

Completed

A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults (B521MAD)

Healthy

Belgium
Pfizer

Completed

Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus

United States
Boehringer Ingelheim

Completed

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men

Healthy

Germany
UCB Biopharma S.P.R.L.

Terminated

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters (ARTEMIS1)

Epilepsy

United States, Australia, Canada, Germany, Hungary, Israel, Italy, New Zealand, Poland, Spain, Ukraine
Boehringer Ingelheim

Completed

Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male Subjects

Healthy
Medical University of Warsaw

Completed

The Effect of Midazolam Premedication on Copeptine Concentration in Blood

Preanesthetic Medication | Copeptin

Poland
Reata, a wholly owned subsidiary of Biogen
Covance

Completed

A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone

Healthy Adult Subjects

United States
DICE Therapeutics, Inc., a wholly owned subsidiary...

Completed

A Drug-Drug Interaction Study Evaluating the Perpetrator Potential of DC-806 on Cocktails of CYP450 Enzyme and Transporter Substrates in Healthy Participants

Healthy Participants

United States
Konkuk University Medical Center
GlaxoSmithKline

Completed

Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy (remifentanil)

Diagnostic Colonoscopy Screening

Korea, Republic of
National Institute of Nursing Research (NINR)

Terminated

Effect of Ketamine on Fatigue Following Cancer Therapy

Cancer | Fatigue | Ketamine

United States
Hamad Medical Corporation

Recruiting

Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children

Procedural Pain | Procedural Anxiety

Qatar
Postgraduate Institute of Medical Education and...

Completed

Dexmedetomidine vs. Midazolam Sedation for Endobronchial Ultrasound

Conscious Sedation During Procedure | Endobronchial Ultrasound

India
VA Office of Research and Development

Completed

Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Major Depressive Disorder | Alcohol Use Disorder

United States
Fulcrum Therapeutics

Completed

Safety, Tolerability and Pharmacokinetics of FTX-6058

Sickle Cell Disease | Healthy Adult Subjects

United States
Universidade Federal de Sergipe
University of Campinas, Brazil

Completed

Three Anxiolytic Drugs Used in Third Molar Surgery

Dental Anxiety | Impacted Third Molar Tooth

Brazil
University Hospital, Lille

Completed

Premedication by Midazolam for Emergency Surgery

Anxiety

France

Search clinical trials for: repaglinide; midazolam; SHR4640 placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations